Fig. 3

Pre- and Post-Intralipid Glucose, Insulin, Triglycerides, and Free Fatty Acids Values. a Average baseline glucose levels measured during infusion of saline or glucose and glucose levels following Intralipid infusion. b Average baseline insulin levels measured during infusion of saline or glucose and insulin levels following Intralipid infusion. c Average baseline FFA levels measured during infusion of saline or glucose and FFA levels following Intralipid infusion. d Average baseline triglycerides levels measured during infusion of saline or glucose and triglycerides levels following Intralipid infusion. $Denotes significant differences at the indicated timepoint in the LS group with respect to the OS group. #Denotes significant differences at the indicated timepoint in the LG groups with respect to the LS group. &Denotes significant differences at the indicated timepoint in the LG groups with respect to the OS group. *Denotes significant differences within group at the indicated Post-Intralipid timepoint with respect to the average Pre-Intralipid/Baseline measure of the same group. Arrow indicates that, for the LG subjects, the 10 % IV glucose infusion was stopped at approximately 11:45. Note: For all symbols: *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001